Myosin Therapeutics Invited to Present at BioFuture 2026 in New York City
, /PRNewswire/ — Myosin Therapeutics today announced that, following its selection as a 2026–2027 National Cancer Institute (NCI) SBIR Investor Initiatives…
Category: Press Releases
n6 Achieves ISO 13485:2016 Certification, Strengthening the Quality Foundation Behind iconPCR™ Instruments
Intertek registration of n6’s quality management system covers the manufacture and service of instrumentation for genetic research , /PRNewswire/ —…
Human Longevity Expands Its $1 Million Cancer Prevention Pledge to Breast Cancer
Breast Cancer Awareness Month initiative supports early detection and eligible members diagnosed with stage IV disease , /PRNewswire/ — Human…
Aignostics lance HETA Clinical, une nouvelle gamme de produits d’IA qui accélèrent les flux de travail de pathologie et réduisent le nombre de tests moléculaires échoués
, /PRNewswire/ — Aignostics a annoncé aujourd’hui le lancement de HETA Clinical, une nouvelle famille de produits d’IA « pan-cancer » couvrant…
CRISPR Market worth $6.12 billion by 2031 – Exclusive Report by MarketsandMarkets™
, /PRNewswire/ — According to MarketsandMarkets™, the CRISPR Market is projected to reach USD 6.12 billion by 2031 from USD 3.48…
Devonian Health Group Provides Update on its Planned NYSE American Listing
, /PRNewswire/ — Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD) (OTCQB: DVHGF) today provides an update on its…
ADHD Drugs Market to Reach USD 22.79 Billion by 2035 – Credence Research
, /PRNewswire/ — The “ADHD Drugs Market – Growth, Share, Opportunities & Competitive Analysis, 2025–2035” report has been added to…
Zifo Recognized by Nasscom for Advancing AI-Driven Lab Transformation
AI Gamechangers recognition highlights Zifo’s practical application of artificial intelligence to accelerate master data creation for lab systems , /PRNewswire/…
Lenire Now Included in U.S. ENT Clinical Practice Guidelines – First New Treatment Added by American Academy of Otolaryngology Since Establishment of the Academy’s Tinnitus Guidelines
The American Academy of Otolaryngology – Head and Neck Surgery Foundation has included Lenire (bimodal neuromodulation) as a treatment option…
Lenire Now Included in U.S. ENT Clinical Practice Guidelines – First New Treatment Added by American Academy of Otolaryngology Since Establishment of the Academy’s Tinnitus Guidelines
The American Academy of Otolaryngology – Head and Neck Surgery Foundation has included Lenire (bimodal neuromodulation) as a treatment option…